Clinical research demonstrates that supervised psychedelic-assisted therapy may decrease depression and anxiety in some patients suffering from life-threatening illnesses and may relieve distress.1 To promote quality end-of-life care and provide peace of mind at the end of life, Compassion & Choices supports ongoing research related to supervised psychedelic-assisted therapy.
Takeaways from our webinar "As the End Nears: Dying With Heart Failure."
Disparities in end-of-life care and planning persist for many historically underserved communities.
Palliative care is not about curing illness, but about providing dignity, comfort and quality of life.
An FAQ to answer your questions about medical aid in dying and the end-of-life choice movement.
In multiple national surveys, across multiple demographics, people support having options to end their suffering.
A growing number of national and state medical organizations have endorsed/adopted a neutral position regarding medical aid in dying as an end-of-life
On June 11, 2019, a new policy position recommended by the Council (CEJA 2-A-19 Report) was adopted.